We pioneer breakthroughs in healthcare. For everyone. Everywhere. Sustainably. Learn more about our purpose, our innovation leadership, our culture, and our strategy.
Siemens Healthineers Launches Innovance D-Dimer 2.0 Assay to Help Clinicians Rule Out, Monitor Serious Blood-clotting Conditions
Tarrytown, New York, USA
Siemens Healthineers launches the CE-marked, FDA-cleared Innovance D-Dimer 2.0 assay. Designed for fast, efficient testing, the assay helps clinicians exclude deep vein thrombosis and pulmonary embolism.
The Future of Radiotherapy is Here: Siemens Healthineers Launches Accela
Boston, USA
Siemens Healthineers launches Accela, the first radiotherapy solution engineered around NeoArc, combining speed and precision for a broad range of cases while improving the scalability of complex treatments and reducing the time patients spend in radiotherapy treatment.
Here you will find all ad hoc announcements (disclosure of inside information according to Article 17 of Regulation (EU) No 596/2014 on market abuse) and announcements of material transactions with related parties in accordance with section 111c of the German Stock Corporation Act of Siemens Healthineers AG.
